Endogenous nitric oxide release modulates mural platelet thrombosis and neutrophil-endothelium interactions under low and high shear conditions

Thrombosis Research

Volumn 85, Issue 4, 1997, Pages 315-326

  Provost, Patrick ^a   Merhi, Yahye ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

L NAME; leukocyte; platelet; shear rate; vessel wall

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; BLOOD VESSEL WALL; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SWINE; THROMBOCYTE; THROMBOSIS;

ANIMALS; BLOOD PRESSURE; CELL ADHESION; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HEMORHEOLOGY; HUMANS; NEUTROPHILS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PLATELET AGGREGATION; SWINE; THROMBOSIS;

EID: 0031568829     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00017-0     Document Type: Article

References (45)

1. PALMER R.M.J., ASHTON D.S., MONCADA S. Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature. 333:1988;664-666.
2. REES D.D., PALMER R.M.J., MONCADA S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA. 86:1989;3375-3378.
3. RADOMSKI M.W., PALMER R.M.J., MONCADA S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 2:1987;1057-1058.
4. KUBES P., SUZUKI M., GRANGER D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA. 88:1991;4651-4655.
5. FUSTER V., BADIMON L., BADIMON J.J., CHESEBRO J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 326:1992;310-318.
6. STEELE P.M., CHESEBRO J.H., STANSON A.W., HOLMES D.R. Jr., DEWANJEE M.K., BADIMON L., FUSTER V. Balloon angioplasty: natural history of the pathophysiological response to injury in a pig model. Circ Res. 57:1985;105-112.
7. MERHI Y., GUIDOIN R., PROVOST P., LEUNG T.-K., LAM J.Y.T. Increase of neutrophil adhesion and vasoconstriction with platelet deposition after deep arterial injury by angioplasty. Am Heart J. 129:1995;445-451.
8. MERHI Y., LAM J.Y.T., LACOSTE L., LATOUR J.G., GUIDOIN R., WATERS D. Effects of thrombocytopenia and shear rate on neutrophil and platelet deposition on endothelial and medial arterial surfaces. Arterioscler Thromb. 13:1993;951-957.
9. BADIMON L., BADIMON J.-J., GALVEZ A., CHESEBRO J.H., FUSTER V. Influence of arterial damage and wall shear rate on platelet deposition. Ex vivo study in a swine model. Arteriosclerosis. 6:1986;312-320.
10. TURITTO, V.T. and BAUMGARTNER, H.R. Platelet-surface interactions. In: Hemostasis and Thrombosis: Basis Principles and Clinical Practice. R.W. Colman, J. Hirsh, V.J. Marder, E.W. Salzman (eds), pp. 364-379, J.B. Lippincott Company, Philadelphia, PA, 1982.
11. SNEDDON J.M., VANE J.R. Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. Proc Natl Acad Sci USA. 85:1988;2800-2804.
12. RADOMSKI M.W., PALMER R.M.J., MONCADA S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol. 92:1987;181-187.
13. RADOMSKI M.W., PALMER R.M.J., MONCADA S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol. 92:1987;639-646.
14. FURLONG B., HENDERSON A.H., LEWIS M.J., SMITH J.A. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol. 90:1987;687-692.
15. PROVOST P., LAM J.Y.T., LACOSTE L., MERHI Y., WATERS D. Endothelium-derived nitric oxide attenuates neutrophil adhesion to endothelium under arterial flow conditions. Arterioscler Thromb. 14:1994;331-335.
16. BADIMON L., BADIMON J.J., TURITTO V.T., FUSTER V. Thrombosis: studies under flow conditions. Ann NY Acad Sci. 516:1987;527-539.
17. GOLDSMITH H.L., TURITTO V.T. Rheological aspects of thrombosis and haemostasis: basic principles and applications. Thromb Haemost. 55:1986;415-435.
18. VALLES J., SANTOS M.T., AZNAR J., MARCUS A.J., MARTINEZ-SALES V., PORTOLES M., BROEKMAN M.J., SAFIER L.B. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. Blood. 78:1991;154-162.
19. BAZZONI G., DEJANA E., DEL MASCHIO A. Platelet-neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica. 76:1991;491-499.
20. DE GRAAF J.C., BANGA J.D., MONCADA S., PALMER R.M.J., DE GROOT P.G., SIXMA J.J. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation. 85:1992;2284-2290.
21. REES D.D., PALMER R.M.J., SCHULZ R., HODSON H.F., MONCADA S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 101:1990;746-752.
22. REES D.D., PALMER R.M.J., HODSON H.F., MONCADA S. A specific inhibitor of nitric oxide formation from l-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol. 96:1989;418-424.
23. RADOMSKI M.W., PALMER R.M.J., MONCADA S. Characterization of the l-arginine: nitric oxide pathway in human platelets. Br J Pharmacol. 101:1990;325-328.
24. COLLER B.S. Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy. Circulation. 92:1995;2373-2380.
25. MICHELSON A.D., BENOIT S.E., FURMAN M.I., BRECKWOLDT W.L., ROHRER M.J., BARNARD M.R., LOSCALZO J. Effects of nitric oxide/EDRF on platelet surface glycoproteins. Am J Physiol. 270:1996;H1640-H1648.
26. LANGFORD E.J., WAINWRIGHT R.J., MARTIN J.F. Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors. Arterioscler Thromb Vasc Biol. 16:1996;51-55.
27. McCALL T., WHITTLE B.J.R., BOUGHTON-SMITH N.K., MONCADA S. Inhibition of FMLP-induced aggregation of rabbit neutrophils by nitric oxide. Br J Pharmacol. 95:1988;517P. (abstract).
28. CLANCY R.M., LESZCZYNSKA-PIZIAK J., ABRAMSON S.B. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest. 90:1992;1116-1121.
29. MOILANEN E., VUORINEN P., KANKAANRANTA H., METSÄ-KETELÄ T., VAPAATALO H. Inhibition by nitric oxide-donors of human polymorphonuclear leukocyte functions. Br J Pharmacol. 109:1993;852-858.
30. RIUTTA A., ALANKO J., MUCHA I., VAPAATALO H. Effects of Trolox C and SIN-1 on arachidonic acid metabolism and on cyclic GMP formation in leukocytes. Eur J Pharmacol. 262:1994;217-222.
31. FORSLUND T., SUNDQVIST T. Nitric oxide reduces hydrogen peroxide production from human polymorphonuclear neutrophils. Eur J Clin Invest. 25:1995;9-14.
32. SCHRÖDER H., NEY P., WODITSCH I., SCHRÖR K. Cyclic GMP mediates SIN-1-induced inhibition of human polymorphonuclear leukocytes. Eur J Pharmacol. 182:1990;211-218.
33. FREIMAN P.C., MITCHELL G.G., HEISTAD D.D., ARMSTRONG M.L., HARRISON D.G. Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ Res. 58:1986;783-789.
34. LEFER A.M., MA X.-l. Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium. Arterioscler Thromb. 13:1993;771-776.
35. MA X.-l., WEYRICH A.S., LEFER D.J., LEFER A.M. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res. 72:1993;403-412.
36. SIEGFRIED M.R., ERHARDT J., RIDER T., MA X.-l., LEFER A.M. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther. 260:1992;668-675.
37. LEFER A.M., SIEGFRIED M.R., MA X.-l. Protection of ischemia-reperfusion injury by sydnonimine NO donors via inhibition of neutrophil-endothelium interaction. J Cardiovasc Pharmacol. 22((Suppl 7)):1993;S27-33.
38. HANSEN P.R. Role of neutrophils in myocardial ischemia and reperfusion. Circulation. 91:1995;1872-1885.
39. TSAO P.S., MA X.-l., LEFER A.M. Activated neutrophils aggravate endothelial dysfunction after reperfusion of the ischemic feline myocardium. Am Heart J. 123:1992;1464-1471.
40. NISHIDA M., KUZUYA T., HOSHIDA S., KIM Y., KITABATAKE A., KAMADA T., TADA M. Polymorphonuclear leukocytes induced vasoconstriction in isolated canine coronary arteries. Circ Res. 66:1990;253-258.
41. WEISS S.J. Tissue destruction by neutrophils. N Engl J Med. 320:1989;365-376.
42. NISHIKAWA M., KANAMORI M., HIDAKA H. Inhibition of platelet aggregation and stimulation of guanylate cyclase by an antianginal agent molsidomine and its metabolites. J Pharmacol Exp Ther. 220:1982;183-190.
43. PROVOST, P. and LAM, J.Y.T. Stimulated release of endothelium-derived relaxing factor attenuates platelet and neutrophil interactions with downstream aortic media. FASEB J 7 (Suppl A), A786 (abstract), 1993.
44. NARUSE K., SHIMIZU K., MURAMATSU M., TOKI Y., MIYAZAKI Y., OKUMURA K., HASHIMOTO H., ITO T. Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. Arterioscler Thromb. 14:1994;746-752.
45. CAYATTE A.J., PALACINO J.J., HORTEN K., COHEN R.A. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb. 14:1994;753-759.